MEDICINAL COMPOSITION CONTAINING FBPase INHIBITOR

摘要

To provide a method of treatment for diabetes mellitus having excellent decreasing activity in blood glucose levels and improving effects for dysfunction of ²-cells in the pancreas of patients with diabetes mellitus. A pharmaceutical composition comprising an FBPase inhibitor and an insulin sensitizer
5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thia zolidine-2,4-dione or a pharmacologically acceptable salt thereof.